Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $3.18 billion. The enterprise value is $3.11 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 122.49 million shares outstanding. The number of shares has increased by 11.93% in one year.
| Current Share Class | 122.49M |
| Shares Outstanding | 122.49M |
| Shares Change (YoY) | +11.93% |
| Shares Change (QoQ) | +4.64% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 75.40% |
| Float | 89.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 66.48 |
| PS Ratio | 10.69 |
| Forward PS | 7.07 |
| PB Ratio | 20.45 |
| P/TBV Ratio | 22.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.50, with a Debt / Equity ratio of 0.72.
| Current Ratio | 3.50 |
| Quick Ratio | 3.07 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.61 |
Financial Efficiency
Return on equity (ROE) is -28.17% and return on invested capital (ROIC) is -7.51%.
| Return on Equity (ROE) | -28.17% |
| Return on Assets (ROA) | -5.91% |
| Return on Invested Capital (ROIC) | -7.51% |
| Return on Capital Employed (ROCE) | -14.10% |
| Weighted Average Cost of Capital (WACC) | 13.40% |
| Revenue Per Employee | $929,617 |
| Profits Per Employee | -$129,602 |
| Employee Count | 342 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, ARQT has paid $1.02 million in taxes.
| Income Tax | 1.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +124.59% in the last 52 weeks. The beta is 1.68, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +124.59% |
| 50-Day Moving Average | 27.99 |
| 200-Day Moving Average | 20.08 |
| Relative Strength Index (RSI) | 44.19 |
| Average Volume (20 Days) | 1,161,870 |
Short Selling Information
The latest short interest is 15.22 million, so 12.43% of the outstanding shares have been sold short.
| Short Interest | 15.22M |
| Short Previous Month | 15.01M |
| Short % of Shares Out | 12.43% |
| Short % of Float | 17.02% |
| Short Ratio (days to cover) | 8.01 |
Income Statement
In the last 12 months, ARQT had revenue of $317.93 million and -$44.32 million in losses. Loss per share was -$0.35.
| Revenue | 317.93M |
| Gross Profit | 286.02M |
| Operating Income | -38.25M |
| Pretax Income | -43.30M |
| Net Income | -44.32M |
| EBITDA | -33.19M |
| EBIT | -38.25M |
| Loss Per Share | -$0.35 |
Full Income StatementBalance Sheet
The company has $191.07 million in cash and $113.77 million in debt, with a net cash position of $77.29 million or $0.63 per share.
| Cash & Cash Equivalents | 191.07M |
| Total Debt | 113.77M |
| Net Cash | 77.29M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 158.07M |
| Book Value Per Share | 1.31 |
| Working Capital | 249.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$32.56 million and capital expenditures -$686,000, giving a free cash flow of -$33.24 million.
| Operating Cash Flow | -32.56M |
| Capital Expenditures | -686,000 |
| Free Cash Flow | -33.24M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
Gross margin is 89.96%, with operating and profit margins of -12.03% and -13.94%.
| Gross Margin | 89.96% |
| Operating Margin | -12.03% |
| Pretax Margin | -13.62% |
| Profit Margin | -13.94% |
| EBITDA Margin | -10.44% |
| EBIT Margin | -12.03% |
| FCF Margin | n/a |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.93% |
| Shareholder Yield | -11.93% |
| Earnings Yield | -1.39% |
| FCF Yield | -1.04% |
Analyst Forecast
The average price target for ARQT is $25.00, which is -3.85% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | -3.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 32.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of 1.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 4 |
